The world's second-biggest Ebola outbreak is still raging. Here's why.

Despite a coordinated response and a vaccine, the Democratic Republic of the Congo’s struggle with the deadly virus seems to have no quick end in sight.

By Nadia Drake
photographs by Nichole Sobecki
Published 18 Jul 2019, 11:30 BST
Clouds hover over Butembo as seen from the site of an attacked Médecins Sans Frontières (MSF) ...
Clouds hover over Butembo as seen from the site of an attacked Médecins Sans Frontières (MSF) Ebola treatment center on March 1, 2019. Aid workers have faced mistrust in some areas in the DRC as they seek to contain the Ebola outbreak, which has become the most severe in Congo’s history. The MSF treatment centre was the second site of such an attack following the Katwa centre, which was set on fire on February 24 by unknown attackers, forcing staff to evacuate patients.
Photograph by Nichole Sobecki
Editor's Note: This story has been updated to reflect the Ebola outbreak's new classification by the World Health Organisation.

The World Health Organisation on Wednesday declared the Ebola outbreak in the Democratic Republic of the Congo a public health emergency of international concern.

“It is time for the world to take notice and redouble our efforts,” said WHO Director-General Dr. Tedros Adhanom Ghebreyesus. “We need to work together in solidarity with the DRC to end this outbreak and build a better health system. Extraordinary work has been done for almost a year under the most difficult circumstances. We all owe it to these responders—coming from not just WHO but also government, partners and communities—to shoulder more of the burden.”

The declaration followed a meeting in Geneva of the international health regulations emergency committee for Ebola in the DRC. The committee, which has met four times since the outbreak was declared in August 2018, cited the first confirmed Ebola case in Goma, a city of nearly 2 million people near the Rwandan border.

The emergency committee expressed frustration with funding delays that have negatively impacted the Ebola response. They also stressed the importance of keeping transportation routes and borders open. Since it was declared almost a year ago the Ebola outbreak has been classified as a level 3 emergency, the most serious, by WHO. 

“It is important that the world follows these recommendations. It is also crucial that states do not use the PHEIC as an excuse to impose trade or travel restrictions, which would have a negative impact on the response and on the lives and livelihoods of people in the region,” said University of Zurich Professor Robert Steffen, chair of the Emergency Committee.

Sixteen-year-old Kavugho Mukoni Romelie is treated for Ebola at the Alliance for International Medical Action centre in Beni, DRC, on February 25, 2019. Romelie is being treated in one of the center's Biosecure Emergency Care Units, known as cubes—a recent advancement in technology to treat the virus. Made of clear, flexible plastic with sleeves, gloves, and bodysuits built into the walls, the cubes allow nurses to safely perform about 80 percent of the care an Ebola patient needs without having to put on hot, cumbersome gowns, hoods, rubber aprons, boots, and goggles.
Photograph by Nichole Sobecki

An Ebola epidemic thundering through heavily populated provinces in the northeastern Democratic Republic of the Congo has sickened 2,512 people and killed 1,676 since the outbreak was declared last August, according to WHO—despite the efforts of specialist medical teams, an effective vaccine, and new treatments that are being tested in the region.

The outbreak already is the second-largest on record, behind the epidemic that burned through West Africa from 2014 to 2016, killing more than 11,300 people. In its most extreme form, the viral hemorrhagic fever leads to uncontrollable bleeding and death.

In this outbreak, the virus appears to be infecting an unusually high number of children and killing a large percentage of people before they’ve sought or received treatment in Ebola centres staffed by local and international aid workers. Now, teams trying to track the spread of the disease are finding fresh cases with no obvious connection to previous patients, leading some health specialists to worry that the end of this epidemic is nowhere in sight.

Efforts to contain the virus also have been hindered by the path of the outbreak, which is spreading through areas marked by a deep distrust of foreigners, and therefore more hesitance to seek treatment. As well, ongoing political strife and violence are tearing through the region—including assaults aimed specifically at Ebola responders—and making it difficult for aid workers to corral the spread of the outbreak.

“I’m not at all optimistic that the epidemic will be brought under control in the near to medium term. All the data point in the direction of an extended epidemic,” says Lawrence Gostin of Georgetown University, director of the WHO Collaborating Center on Global Health Law. “With ongoing community distrust and explosive violence, and no concrete plan to overcome these obstacles, cases will increase with potential regional or global transmission.”

Any delay in treatment makes the virus more dangerous by giving it more chances to kill and spread, says Natalie Roberts, emergency operations coordinator for Médecins Sans Frontières (MSF), also known as Doctors Without Borders.

“You have a window of time in which treatment is effective. Wait too long, the patient dies anyway, and people lose confidence” in treatment, Roberts says. “Like any disease, the more severe it gets, the less likely any treatment is going to have an impact.”

Violence and viruses

The first embers of this outbreak began to smolder last summer, when cases started appearing in northeast Congo. This is the tenth time Ebola has emerged in the country, and as before, the virus crept out of a still-unidentified natural reservoir. Named after a river in Congo where it first appeared in 1976, the virus under a microscope resembles a kinked strand of spaghetti. It works its ways into cells, creates countless copies of itself, and destroys the connections between tissues, causing organ failure and leaky blood vessels, and essentially dismantling bodies from the inside out.

A colorised scanning electron micrograph reveals the distinct filamentous shape of the Ebola virus budding from a monkey's kidney cell.
Photograph by Universal History Archive, UIG via Getty Images

But transmitting Ebola is not exactly simple: The virus travels between humans through infected bodily fluids and tissues, but infiltrating a second host requires going in through broken skin or a mucous membrane, such as the eyes or nose.

“Ebola is not the most infectious disease in the world,” Roberts says. “It’s a very lethal disease, and it’s got a high mortality rate, but it’s not that infectious.”

Yet during the past 10 months, those first embers have ignited a viral fire. Because of the outbreak, the DRC delayed a presidential election in three affected areas and agencies including MSF, the WHO and the U.S. Centers for Disease Control and Prevention (CDC) moved response teams into North Kivu and Ituri provinces.

Efforts to contain the epidemic have been stymied by local reluctance to seek or accept aid from foreigners, a partial reflection of the long-held mistrust of authority in a region torn by civil conflict. In some cities, residents even launched targeted attacks on Ebola diagnostic and treatment facilities, recently burning one MSF centre largely to the ground, and prompting the temporary evacuation of various response teams. Now, aid workers are trickling back in.

Healthcare workers prepare the body of a young girl for a safe and dignified burial by her family at the general hospital in Kyondo, DRC, on March 4, 2019. The young girl died soon after reaching the hospital and was only tested for Ebola post-mortem, making the cause of her death unknown at the time these images were made. Because Kyondo is an hour and a half from the nearest city and receiving test results can be delayed, for the past few months, all patients who die here have received a safe and dignified burial regardless of cause of death. Safely burying people whose lives were claimed by Ebola is critical to controlling and containing the outbreak, because the body of a person who died of the virus is still highly infectious.
Photograph by Nichole Sobecki

“We have increased the footprint of CDC staff in-country over the past month,” says the CDC’s Inger Damon, co-lead of the Ebola response. “What we’re really trying to focus on, since we haven’t been able to get into some of the heavily affected areas, is working with teams on the ground to look carefully at the data that’s been collected and find the gaps where we can help to focus additional efforts.”

Vaccine shows promise

Three sisters sit with their 14-year-old brother Kakule Kavendivwa, a suspected Ebola case, in a private clinic in Beni on February 27, 2019. The day before, they had gone to a nearby health center, but when the team there encouraged them to take their brother to the Ebola Treatment Center, they fled. The health center alerted the World Health Organization, which found the family. After several hours of talking with community outreach workers, they agreed to allow an ambulance to be called to take Kavendivwa to the Ebola Treatment Center.

Photograph by Nichole Sobecki
A young man waits outside a private clinic in Beni on February 27, 2019, with an Ebola prevention poster on the wall behind him.
Photograph by Nichole Sobecki

Health workers aren’t fighting the epidemic empty-handed. Besides four different treatments currently being field-tested, teams have a powerful weapon in their arsenal: the rVSV-ZEBOV vaccine, developed by Canadian scientists in the early 2000s and tested in Guinea in 2015. It’s made of an animal virus engineered to wear a non-lethal Ebola virus protein, which provokes the human immune system into mounting a pre-emptive defence.

Still officially unlicensed by the U.S. Food and Drug Administration, the vaccine is being donated by its manufacturer, Merck, and distributed under compassionate use protocols.

As of May 7, more than 111,000 people have been vaccinated. Most of those, according to the WHO, are primary or secondary contacts of Ebola patients—people such as health care providers or family members with a high likelihood of being infected. Those folks are identified through contact-tracing, a process used to track disease transmission and, ideally, halt its spread. The idea, Roberts says, is to create a ring of vaccinated individuals around a patient, and then create yet another ring around those primary contacts.

“You’re not necessarily protecting the contacts because they might have already contracted Ebola by the time you’ve confirmed the case,” she says. “But if you then vaccinate their contacts, you should be able to prevent them from getting Ebola – and therefore stop the epidemic.”

The WHO reports that so far, rVSV-ZEBOV-GP is proving highly effective, especially when administered early enough. No deaths have been reported among people who developed Ebola symptoms more than 10 days post-vaccination. As well, the overall fatality rate is lower among all vaccinated individuals, regardless of when they develop the disease.

So, with an extremely effective vaccine in hand, and more supplies on the way, why is the epidemic still out of control?

“The strategy looks fine on paper and theoretically we understand why it should work, but in practice we’re just questioning how feasible it is,” Roberts says. “We do have a good vaccine but it’s not managing to control the epidemic.”

Pinpointing the virus

Roberts and Damon both point to the same few reasons preventing the epidemic’s end.

For starters, people in the northeastern DRC are highly mobile and the region has hundreds of health care providers, ranging from private clinics to traditional healers to pharmacies. Many common diseases, such as measles or malaria, share initial symptoms with Ebola—meaning that identifying Ebola in its early stages is not necessarily easy. As of right now, the disease can be diagnosed only at specialised centers, which makes it tricky to quickly isolate patients and begin treatment.

Workers wash the wheels of vehicles with chlorinated water and check people's temperatures at Mukulya checkpoint on the road between Beni and Butembo on February 27, 2019. The government imposed an array of checkpoints along the road in a bid to quarantine areas affected by Ebola.
Photograph by Nichole Sobecki

“We’re seeing that many of the cases subsequently identified as Ebola cases will transit through one or two health care facilities prior to be identified,” Damon says.

Along the way, those patients come into contact with multiple caregivers and other patients—and then, by close contact with doctors, nurses and others, often unknowingly spread the virus. This type of disease transmission in health care facilities, termed nosocomial, is especially prevalent among children, Roberts says.

“They get admitted to a health facility with another medical problem and end up sharing a bed or may even equipment,” she says. “There’s actually more children getting sick with Ebola than we’d expect.”

By the time Ebola has been diagnosed, it’s sometimes too late for treatment to help. Perhaps most alarmingly, Damon reports that lots of people are dying at home rather than in Ebola treatment centres, suggesting that they aren’t seeking or accepting treatment early enough, if at all. These community deaths make it even harder to isolate cases, trace contacts, and effectively deploy vaccines.

“Over the past couple of weeks, it has been very disheartening that over 30 percent of the cases have been identified as deaths in the community,” Damon says. “There’s a longer period of time when there’s potential additional transmission to others who cared for these individuals before their death.”

New strategies

Family and friends view the body of police officer Tabu Amuli Emmanuel in the Matanda Hospital morgue in Butembo on March 2, 2019. Just over a week after the attack that killed Emmanuel, the same centre was attacked again, killing another policeman and wounding a health worker.
Photograph by Nichole Sobecki

Quelling the rising numbers of Ebola victims will require some shifts in how teams work in the region.

Damon says that paying more attention to how teams interact with communities is crucial, and that CDC behavioural scientists are studying how information can be shared most effectively with local communities. The goal, she says, is to promote understanding and trust.

“It’s difficult to understand who can be the most effective messengers and identify them and train them, and have them better understand the disease and response effort,” she says.

In areas of the DRC where response efforts have successfully meshed with existing community structures and expectations, “we have seen outbreaks end,” says Tarik Jasarevic, WHO spokesperson. WHO teams work daily to engage communities in the disease response, gathering information about concerns, criticisms, beliefs and observations, and working to gain access to hostile areas. As a result, Jasarevic says, the vast majority of people eligible for vaccinations accept the vaccine, and a large percentage of families are conducting safe and dignified burials in areas where funerals are normally hotspots for disease transmission.

But Roberts points to another, perhaps more systemic factor that could be changed: the centralised Ebola facilities. She suspects that if it were possible for local health care providers to diagnose Ebola, outcomes would be better. Patients would receive treatment more quickly, they wouldn’t need to travel as far, and teams could vaccinate contacts before the disease spreads further.

“I really think if we could test people closer to home, then that would change an awful lot,” she says. “We could deploy the vaccine in a more simple manner. We could get much more quickly on top of the epidemic…. Right now, we can’t follow the chains of transmission, we don’t really know where the next case is going to appear.”

Read More

You might also like

Science and Technology
Should people take more than one type of COVID-19 vaccine?
Science and Technology
Why Moderna may have an edge in the vaccine race: refrigeration
Science and Technology
Pfizer vaccine results are promising, but lack of data ‘very concerning,’ experts say
Science and Technology
Fauci ‘seriously doubts’ the Russia vaccine is ready for widespread use
Science and Technology
Dozens of COVID-19 vaccines are in development. Here are the ones to follow.

Explore Nat Geo

  • Animals
  • Environment
  • History & Culture
  • Science
  • Travel
  • Photography
  • Space
  • Adventure
  • Video

About us


  • Magazines
  • Newsletter
  • Disney+

Follow us

Copyright © 1996-2015 National Geographic Society. Copyright © 2015-2021 National Geographic Partners, LLC. All rights reserved